Mounjaro (tirzepatide) is used for type 2 diabetes to help lower blood sugar levels, and tirzepatide also causes weight loss. Mounjaro is a once-weekly injection that should be used alongside dietary changes and exercise. Mounjaro received FDA approval on May 13, 2022.
